NOTE: This protocol for detergent screening is detailed for 30 g of HEK293 cell pellet as starting material.
1. Materials, chemicals and reagents
NOTE: All solutions are prepared using analytical grade reagents and ultrapure water, which is purified from deionized water to reach a resistivity of 18.2 MΩ∙cm at 25 °C.
2. Cell membrane solubilization and protein extraction
3. UV-VIS spectroscopy
4. Automated size-exclusion chromatography of rhodopsin and rhodopsin–mini-Go complex
5. Deglycosylation and LC-MS study
The experimental workflow for sample preparation and analysis is summarized in Figure 1. Using open columns for small-scale affinity purification allowed us to prepare samples in many different detergent conditions in parallel (Figure 1A). Such a small-scale purification set-up yielded sufficient protein for further analyses using UV-VIS spectroscopy, SEC and SDS-PAGE (Figure 1B-C).
UV-VIS spectroscopy revealed rhodopsin stability
Stability of the retinal-reconstituted rhodopsin was assessed by its optical absorbance (Figure 2). In the dark state, 9-cis retinal is covalently linked to Lys296 as a protonated Schiff base. After illumination, the 9-cis retinal is isomerized to the all-trans isoform and the Schiff base link is deprotonated. The protonated 9-cis retinal gives an absorption peak at 488 nm, while the deprotonated all-trans retinal has a peak at 380 nm. The UV-VIS spectra of rhodopsin in DDM showed the typical absorption of 9-cis retinal-bound and light-activated rhodopsin, where a blue shift of 108 nm with roughly the same optical density was clearly observed (Figure 2A, upper left panel). When rhodopsin is destabilized, and then the binding pocket for retinal changes, which results in retinal deprotonation and possibly dissociation. If this happens, and then the spectrum shows the contribution from deprotonation as well as the free form of retinal15. Therefore, we determined the efficiency of retinal reconstitution into rhodopsin by the absorbance ratio between the protein (280 nm) and the retinal (488 nm for protonated 9-cis retinal, 380 nm for deprotonated all-trans retinal) (Figure 2B). Rhodopsin samples purified in the classical detergents (DDM, DM, Cymal-6, Cymal-5, C9G) show the same optical profile. However, the samples purified in the NPG detergents (LMNG, DMNG, Cymal-6NG, Cymal-5NG) show optical profiles suggesting a sub-optimal binding environment for retinal except for the OGNG sample, which gave the same optical profile as the DDM sample.
Size-exclusion chromatography showed sample purity and protein monodispersity.
SEC is an efficient and robust analytical tool for evaluating protein samples during preparation and screening. It validates sample purity from the previous purification step as well as the monodispersity of the protein molecules. For rhodopsin and its mini-Go complex, the sample quality was interpreted from the absorption curves at 280 nm and 380 nm (Figure 3A). The 280 nm traces showed the presence of protein, and the 380 nm trace showed the presence of retinal. Any signals appearing in the void volume (around 8 mL when using this column) were attributed to protein aggregates. Therefore, the results showed that samples prepared in the classical detergents were in a monodisperse state except for C9G, where some portion of aggregate appeared. In contrast, samples prepared using the NPG-type detergents contained much more aggregates than the C9G sample; LMNG and Cymal-6NG led to the most aggregate formation, but less aggregates were observed in DMNG and Cymal-5NG. The exception was OGNG, which showed a similar profile to DDM. Protein aggregates eluting at the void volume also had poorer retinal occupancy, as shown by the A280/A380 ratio that had increased in comparison to the peak at the retention volume of ~12.9 mL corresponding to 135 kDa. Another feature we observed was that both rhodopsin and rhodopsin–mini-Go eluted around the same retention volume (Figure 3B). This is unsurprising, because the apparent molecular weight of detergent-bound rhodopsin was 120 kDa and that of rhodopsin–mini-Go 144 kDa. We therefore could not ascertain complex formation merely from the SEC data, so SDS-PAGE was used to further analyze the SEC-purified sample.
SDS-PAGE confirmed complex formation
SDS-PAGE is a standard method to identify the protein components in a sample. Concentrated rhodopsin (prior to SEC purification) were analyzed by SDS-PAGE to confirm its purity, and showed two bands near 37 kDa and a smeared band above 50 kDa (Figure 4A). The lower two bands were later confirmed to have different N-glycosylation states. The band above 50 kDa was interpreted as aggregated rhodopsin oligomers induced by the SDS-PAGE sample buffer because these aggregates were not observed in SEC or any other detection methods. As SEC data could not confirm complex formation, the SEC eluted fractions from rhodopsin–mini-Go samples were analyzed using SDS-PAGE. The SDS-PAGE showed protein bands of both rhodopsin and mini-Go in all the detergent conditions, suggesting the complex was formed regardless of the choice of detergent (Figure 4B).
LC-MS spectrometry identified the N-glycosylation pattern in rhodopsin
Rhodopsin samples from both affinity purification and SEC showed two protein bands that migrated with an apparent molecular weight of about 37 kDa on an SDS-PAGE gel, which could not be separated by SEC when using a 24-mL column. Different patterns of N-glycosylation on the heterologously-expressed rhodopsin from HEK 293 GnTI– cells was the most likely explanation. Therefore, two enzymes, PNGase F and Endo F1, were tested for their ability to deglycosylate rhodopsin. From the SDS-PAGE data, Endo F1 reduced the molecular weight of both protein bands into a single product, while PNGase F digestion still gave two populations (Figure 5A). The undigested and Endo F1-treated samples were analyzed using LC-MS spectrometry to identify the masses of different species. The data showed that rhodopsin produced in HEK 293 GnTI– cells contained either one or two N-glycans, with a difference in mass of 1014±1 Da. Endo F1-treated rhodopsin did not contain any N-glycans and had a mass difference of 2027±1 Da compared to rhodopsin containing two N-glycans. These results are consistent with the absence of the enzyme N-acetylglucosaminyltransferase I in the cell line used to express rhodopsin, which results in all N-glycans having the structure GlcNAc2Man5, (mass 1014 Da).
Figure 1: Sample preparation and characterization for detergent screening experiment. (A) Preparation of rhodopsin samples in different detergents during purification. (B) Methods used in the protocol: UV-VIS spectroscopy, size-exclusion chromatography (SEC), SDS-PAGE and liquid chromatography-mass spectrometry (LC-MS). (C) Experimental workflow for characterization of rhodopsin, rhodopsin–mini-Go, and deglycosylation product of rhodopsin. Please click here to view a larger version of this figure.
Figure 2: UV-VIS spectroscopy of rhodopsin. (A) UV-VIS spectra of rhodopsin. The spectra of the dark-state, 9-cis retinal-bound rhodopsin are shown in blue curves. After illumination, 9-cis retinal is deprotonated and isomerizes into all-trans retinal, and the spectra of illuminated rhodopsin are shown as red curves. The chemical structure of each detergent is shown as an inset. (B) The ratios of A280/A488 (blue bar) and A280/A380 (red bar) depict the stability of rhodopsin in the dark state and light state, respectively. Please click here to view a larger version of this figure.
Figure 3: Size-exclusion chromatography profiles of rhodopsin and rhodopsin–mini-Go complex purified in 10 different detergents. (A) The left panel shows the SEC profiles of samples purified in the classical detergents. The right panel represents the SEC profiles of samples purified in the NPG type detergents. The profile of the standard marker proteins is shown as overlay together with the DDM sample. The interpretation of the peak profiles is shown for DMNG, with the ideal scenario (no aggregates) seen for DDM, DM, Cymal-6, Cymal-5 and OGNG. (B) The magnified profile of the OGNG sample in the retention volume of 12-14 mL. All samples were analyzed using a Superdex200 Increase 10/300 GL column. Please click here to view a larger version of this figure.
Figure 4: SDS-PAGE analysis of rhodopsin and rhodopsin/mini-Go complex. (A) Rhodopsin samples purified in detergents. The smeared band above 50 kDa is attributed to the aggregated rhodopsin oligomers induced by the SDS-PAGE sample buffer. (B) SEC-purified samples of rhodopsin/mini-Go complex. Rhodopsin with 1 and 2 N-glycan and mini-Go are depicted. Please click here to view a larger version of this figure.
Figure 5: Identification of glycosylation in rhodopsin. (A) SDS-PAGE analysis of deglycosylated rhodopsin using PNGase F and Endo F1. (B) LC-MS spectra of rhodopsin without (upper panel) and with deglycosylation by Endo F1 (lower panel). For preparing the rhodopsin–mini-Go complex for crystallization, we chose Endo F1 over PNGase F because Endo F1 delivered one single homogeneous species of rhodopsin. Please click here to view a larger version of this figure.
Detergent | Working concentration (%) | Critical micelle concentration (%) |
DDM | 0.025 | 0.0087 |
DM | 0.12 | 0.087 |
Cymal-6 | 0.05 | 0.028 |
Cymal-5 | 0.2 | 0.12 |
C9G | 0.5 | 0.2 |
LMNG | 0.01 | 0.001 |
DMNG | 0.01 | 0.0034 |
Cymal-6NG | 0.015 | Not available; should be lower than 0.056 |
Cymal-5NG | 0.02 | 0.0056 |
OGNG | 0.15 | 0.058 |
Table 1: Buffer C detergent concentrations.
Time (min) | Solvent A (%) | Solvent B (%) | Solvent C (%) | Flow rate (ml/min) |
0 | 0 | 95 | 5 | 0.5 |
1 | 0 | 95 | 5 | 0.5 |
5 | 20 | 75 | 5 | 0.6 |
25 | 85 | 10 | 5 | 0.6 |
26 | 90 | 5 | 5 | 0.6 |
30 | 90 | 5 | 5 | 0.6 |
Table 2: Column elution parameters.
1D4 peptide | Peptide2.0 | Under request | |
9-cis retinal | Sigma-Aldrich | R5754 | |
Autosampler A-900 | GE Healthcare | Discontinued | |
C9G | Anatrace | N324 | |
cOmplete, EDTA-free protease inhibitor coctail | Roche | 5056489001 | |
Cymal-5 | Anatrace | C325 | |
Cymal-5NG | Anatrace | NG325 | |
Cymal-6 | Anatrace | C326 | |
Cymal-6NG | Anatrace | NG326 | |
DDM | Anatrace | D310 | |
DM | Anatrace | D322 | |
DMNG | Anatrace | NG322 | |
Econo column | Bio-Rad | 7372512 | |
Ettan LC | GE Healthcare | Discontinued | |
FRAC-950 | GE Healthcare | Discontinued | |
HPLC Water 2795 Separation Module | Waters AG | 720000358EN | |
InstantBlue Protein Stain | Expedeon | ISB1L | |
LCT Premier mass spectrometer (ESI-TOF) | Waters AG | – | |
LMNG | Anatrace | NG310 | |
Monitor UV-900 | GE Healthcare | 18110835 | |
Nanodrop 1000 | Witec AG/ThermoFisher | Discontinued | |
NuPAGE 4-12% Bis-Tris gel 1.0 mm, 15 well | ThermoFisher | NP0323BOX | |
NuPAGE MES SDS buffer (20x) | ThermoFisher | NP0002 | |
OGNG | Anatrace | NG311 | |
PAGEr Minigel Chamber | Lonza | 59905 | |
Reprosil 200 C18-AQ column | Morvay Analytik GmbH | #s1503 | |
Superdex 200 Increase GL column | GE Healthcare | 28990944 | |
Tabletop centrifuge 5424R | Eppendorf | 5404000413 | |
Ultracentrifuge Optima XE-100 | Beckmann Coulter | A94516 | |
ULTRA-TURRAX T25 | IKA WERKE | 0003725003 | |
UV-VIS spectrophotometer | Shimadzu | UV-2401PC | |
Waters 2487 Dual λ Absorbance Detector | Waters AG | – |
The key to determining crystal structures of membrane protein complexes is the quality of the sample prior to crystallization. In particular, the choice of detergent is critical, because it affects both the stability and monodispersity of the complex. We recently determined the crystal structure of an active state of bovine rhodopsin coupled to an engineered G protein, mini-Go, at 3.1 Å resolution. Here, we detail the procedure for optimizing the preparation of the rhodopsin–mini-Go complex. Dark-state rhodopsin was prepared in classical and neopentyl glycol (NPG) detergents, followed by complex formation with mini-Go under light exposure. The stability of the rhodopsin was assessed by ultraviolet-visible (UV-VIS) spectroscopy, which monitors the reconstitution into rhodopsin of the light-sensitive ligand, 9-cis retinal. Automated size-exclusion chromatography (SEC) was used to characterize the monodispersity of rhodopsin and the rhodopsin–mini-Go complex. SDS-polyacrylamide electrophoresis (SDS-PAGE) confirmed the formation of the complex by identifying a 1:1 molar ratio between rhodopsin and mini-Go after staining the gel with Coomassie blue. After cross-validating all this analytical data, we eliminated unsuitable detergents and continued with the best candidate detergent for large-scale preparation and crystallization. An additional problem arose from the heterogeneity of N-glycosylation. Heterologously-expressed rhodopsin was observed on SDS-PAGE to have two different N-glycosylated populations, which would probably have hindered crystallogenesis. Therefore, different deglycosylation enzymes were tested, and endoglycosidase F1 (EndoF1) produced rhodopsin with a single species of N-glycosylation. With this strategic pipeline for characterizing protein quality, preparation of the rhodopsin–mini-Go complex was optimized to deliver the crystal structure. This was only the third crystal structure of a GPCR–G protein signaling complex. This approach can also be generalized for other membrane proteins and their complexes to facilitate sample preparation and structure determination.
The key to determining crystal structures of membrane protein complexes is the quality of the sample prior to crystallization. In particular, the choice of detergent is critical, because it affects both the stability and monodispersity of the complex. We recently determined the crystal structure of an active state of bovine rhodopsin coupled to an engineered G protein, mini-Go, at 3.1 Å resolution. Here, we detail the procedure for optimizing the preparation of the rhodopsin–mini-Go complex. Dark-state rhodopsin was prepared in classical and neopentyl glycol (NPG) detergents, followed by complex formation with mini-Go under light exposure. The stability of the rhodopsin was assessed by ultraviolet-visible (UV-VIS) spectroscopy, which monitors the reconstitution into rhodopsin of the light-sensitive ligand, 9-cis retinal. Automated size-exclusion chromatography (SEC) was used to characterize the monodispersity of rhodopsin and the rhodopsin–mini-Go complex. SDS-polyacrylamide electrophoresis (SDS-PAGE) confirmed the formation of the complex by identifying a 1:1 molar ratio between rhodopsin and mini-Go after staining the gel with Coomassie blue. After cross-validating all this analytical data, we eliminated unsuitable detergents and continued with the best candidate detergent for large-scale preparation and crystallization. An additional problem arose from the heterogeneity of N-glycosylation. Heterologously-expressed rhodopsin was observed on SDS-PAGE to have two different N-glycosylated populations, which would probably have hindered crystallogenesis. Therefore, different deglycosylation enzymes were tested, and endoglycosidase F1 (EndoF1) produced rhodopsin with a single species of N-glycosylation. With this strategic pipeline for characterizing protein quality, preparation of the rhodopsin–mini-Go complex was optimized to deliver the crystal structure. This was only the third crystal structure of a GPCR–G protein signaling complex. This approach can also be generalized for other membrane proteins and their complexes to facilitate sample preparation and structure determination.
The key to determining crystal structures of membrane protein complexes is the quality of the sample prior to crystallization. In particular, the choice of detergent is critical, because it affects both the stability and monodispersity of the complex. We recently determined the crystal structure of an active state of bovine rhodopsin coupled to an engineered G protein, mini-Go, at 3.1 Å resolution. Here, we detail the procedure for optimizing the preparation of the rhodopsin–mini-Go complex. Dark-state rhodopsin was prepared in classical and neopentyl glycol (NPG) detergents, followed by complex formation with mini-Go under light exposure. The stability of the rhodopsin was assessed by ultraviolet-visible (UV-VIS) spectroscopy, which monitors the reconstitution into rhodopsin of the light-sensitive ligand, 9-cis retinal. Automated size-exclusion chromatography (SEC) was used to characterize the monodispersity of rhodopsin and the rhodopsin–mini-Go complex. SDS-polyacrylamide electrophoresis (SDS-PAGE) confirmed the formation of the complex by identifying a 1:1 molar ratio between rhodopsin and mini-Go after staining the gel with Coomassie blue. After cross-validating all this analytical data, we eliminated unsuitable detergents and continued with the best candidate detergent for large-scale preparation and crystallization. An additional problem arose from the heterogeneity of N-glycosylation. Heterologously-expressed rhodopsin was observed on SDS-PAGE to have two different N-glycosylated populations, which would probably have hindered crystallogenesis. Therefore, different deglycosylation enzymes were tested, and endoglycosidase F1 (EndoF1) produced rhodopsin with a single species of N-glycosylation. With this strategic pipeline for characterizing protein quality, preparation of the rhodopsin–mini-Go complex was optimized to deliver the crystal structure. This was only the third crystal structure of a GPCR–G protein signaling complex. This approach can also be generalized for other membrane proteins and their complexes to facilitate sample preparation and structure determination.